Skip to results
Modify your search
NARROW
1-20 of 22
Authors: Kevin Oh
Journal Article
RADT-12 HIPPOCAMPAL AVOIDANCE WHOLE BRAIN RADIOTHERAPY WITH REDUCED WHOLE BRAIN DOSE ENABLES IMPROVED SPARING OF HIPPOCAMPI WITHOUT INCREASED RISK OF DISTANT BRAIN FAILURE IN NON-SMALL CELL LUNG CANCER Open Access
Neuro-Oncology Advances, Volume 6, Issue Supplement_1, August 2024, Page i32, https://doi.org/10.1093/noajnl/vdae090.104
Published: 02 August 2024
Journal Article
Abnormal vascular structure and function within brain metastases is linked to pembrolizumab resistance Free
Neuro-Oncology, Volume 26, Issue 5, May 2024, Pages 965–974, https://doi.org/10.1093/neuonc/noad236
Published: 09 December 2023
Journal Article
CTIM-02. PHASE 2 TRIAL OF PEMBROLIZUMAB FOR PATIENTS WITH BRAIN METASTASES OF DIVERSE HISTOLOGIES Free
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Pages v60–v61, https://doi.org/10.1093/neuonc/noad179.0242
Published: 10 November 2023
Journal Article
Therapeutic Role of Tamoxifen for Triple-Negative Breast Cancer: Leveraging the Interaction Between ERβ and Mutant p53 Open Access
The Oncologist, Volume 28, Issue 4, April 2023, Pages 358–363, https://doi.org/10.1093/oncolo/oyac281
Published: 11 February 2023
Journal Article
RADT-24. PHASE II STUDY OF PROTON RADIATION THERAPY FOR LOWER GRADE GLIOMAS Free
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Page vii54, https://doi.org/10.1093/neuonc/noac209.214
Published: 14 November 2022
Journal Article
CTIM-30. PHASE II TRIAL OF PEMBROLIZUMAB IN RECURRENT AND RESIDUAL HIGH-GRADE MENINGIOMAS Free
Neuro-Oncology, Volume 23, Issue Supplement_6, November 2021, Page vi57, https://doi.org/10.1093/neuonc/noab196.222
Published: 12 November 2021
Journal Article
CTIM-02. PHASE II STUDY OF IPILIMUMAB AND NIVOLUMAB IN LEPTOMENINGEAL CARCINOMATOSIS Free
Neuro-Oncology, Volume 23, Issue Supplement_6, November 2021, Page vi49, https://doi.org/10.1093/neuonc/noab196.194
Published: 12 November 2021
Journal Article
CTIM-01. PHASE II TRIAL OF PEMBROLIZUMAB AND LENVATINIB FOR LEPTOMENINGEAL METASTASES Free
Neuro-Oncology, Volume 23, Issue Supplement_6, November 2021, Pages vi48–vi49, https://doi.org/10.1093/neuonc/noab196.193
Published: 12 November 2021
Journal Article
BIOM-04. SENSITIVE DETECTION OF LEPTOMENINGEAL DISEASE USING CELL-FREE DNA FROM CEREBROSPINAL FLUID Free
Neuro-Oncology, Volume 23, Issue Supplement_6, November 2021, Page vi10, https://doi.org/10.1093/neuonc/noab196.035
Published: 12 November 2021
Journal Article
IMMU-08. PHASE II TRIAL OF PEMBROLIZUMAB AND LENVATINIB FOR LEPTOMENINGEAL METASTASES Open Access
Neuro-Oncology Advances, Volume 3, Issue Supplement_4, October 2021, Page iv6, https://doi.org/10.1093/noajnl/vdab112.021
Published: 21 September 2021
Journal Article
NIMG-05. ADVANCED IMAGING TO ASSESS LONGITUDINAL VASCULAR CHANGES IN BRAIN METASTASES TREATED WITH CHECKPOINT INHIBITION Free
Neuro-Oncology, Volume 22, Issue Supplement_2, November 2020, Page ii147, https://doi.org/10.1093/neuonc/noaa215.618
Published: 09 November 2020
Journal Article
INNV-27. THE IMPACT OF A DEDICATED MULTIDISCIPLINARY TUMOR BOARD ON CARE FOR PATIENTS WITH BRAIN METASTASES Free
Neuro-Oncology, Volume 21, Issue Supplement_6, November 2019, Pages vi135–vi136, https://doi.org/10.1093/neuonc/noz175.568
Published: 11 November 2019
Journal Article
CMET-33. PHASE II STUDY OF PALBOCICLIB IN BRAIN METASTASES HARBORING CDK PATHWAY ALTERATIONS Free
Neuro-Oncology, Volume 21, Issue Supplement_6, November 2019, Pages vi58–vi59, https://doi.org/10.1093/neuonc/noz175.234
Published: 11 November 2019
Journal Article
Upfront Surgical Resection of Melanoma Brain Metastases Provides a Bridge Toward Immunotherapy‐Mediated Systemic Control Free
The Oncologist, Volume 24, Issue 5, May 2019, Pages 671–679, https://doi.org/10.1634/theoncologist.2018-0306
Published: 22 February 2019
Journal Article
CMET-16. THE ROLE OF SURGICAL RESECTION OF MELANOMA BRAIN METASTASES IN THE IMMUNOTHERAPY ERA Free
Neuro-Oncology, Volume 20, Issue suppl_6, November 2018, Pages vi56–vi57, https://doi.org/10.1093/neuonc/noy148.228
Published: 05 November 2018
Journal Article
NIMG-63. ADVANCED IMAGING FOR ASSESSING VOLUMETRIC RESPONSES IN BRAIN METASTASES TREATED WITH CHECKPOINT BLOCKADE Free
Neuro-Oncology, Volume 20, Issue suppl_6, November 2018, Page vi190, https://doi.org/10.1093/neuonc/noy148.787
Published: 05 November 2018
Journal Article
CMET-20. EVIDENCE OF CNS RESPONSE OF PEMBROLIZUMAB FOR LEPTOMENINGEAL CARCINOMATOSIS AT A SINGLE CELL RESOLUTION Free
Neuro-Oncology, Volume 20, Issue suppl_6, November 2018, Pages vi57–vi58, https://doi.org/10.1093/neuonc/noy148.232
Published: 05 November 2018
Journal Article
CMET-16. THE ROLE OF SURGICAL RESECTION OF MELANOMA BRAIN METASTASES IN THE IMMUNOTHERAPY ERA Free
Neuro-Oncology, Volume 19, Issue suppl_6, November 2017, Page vi42, https://doi.org/10.1093/neuonc/nox168.165
Published: 06 November 2017
Journal Article
RTHP-08. HIPPOCAMPAL AVOIDANCE WHOLE BRAIN RADIATION THERAPY (HA-WBRT) PLUS SIMULTANEOUS INTEGRATED BOOST (SIB) TO GROSS DISEASE: AN ALTERNATIVE TO WHOLE BRAIN RADIATION (WBRT) WITH STEREOTACTIC RADIOSURGERY (SRS)? Free
Neuro-Oncology, Volume 19, Issue suppl_6, November 2017, Pages vi220–vi221, https://doi.org/10.1093/neuonc/nox168.893
Published: 06 November 2017
Journal Article
NTOX-06. INCREASE OF PSEUDOPROGRESSION AND TREATMENT RELATED EFFECTS IN LOW-GRADE GLIOMA PATIENTS TREATED WITH PROTON RADIATION AND TEMOZOLOMIDE Free
Neuro-Oncology, Volume 19, Issue suppl_6, November 2017, Page vi166, https://doi.org/10.1093/neuonc/nox168.674
Published: 06 November 2017
